Global COVID-19 vaccine equity and the booster dose in low-resource countries: A decolonizing global health perspective

Authors

  • M. A. Rifat Karolinska Institutet
  • Md. Nazmul Huda Western Sydney University
  • Ateeb Ahmad Parray BRAC University
  • Uday Narayan Yadav Australian National University
  • Rashidul Alam Mahumud University of Sydney
  • ARM Mehrab Ali ARCED Foundation
  • Sabuj Kanti Mistry University of New South Wales

DOI:

https://doi.org/10.31646/gbio.160

Keywords:

COVID-19 pandemic, Booster dose, Lower middle-income countries, Vaccine equity, decolonizing global health

Abstract

On July 30, 2021, the administration of a third (booster) dose of the COVID-19 vaccine was introduced to enhance immunity among vaccinated people. Many developed countries have introduced vaccine booster doses as additional protection for their population to mitigate the severity of the ongoing COVID-19 pandemic. However, this idea is currently being replicated by low- and lower-middle-income countries (LMICs), where full vaccination coverage is, as of now, still below 45%, which is considerably lower than that of high-income countries (73%). This commentary focuses on the critiques of introducing booster dose strategy in low-income countries. We highlight different decolonizing global health perspectives, including vaccine equity, effective resource utilization, and priority setup, in this commentary.

Published

2022-08-02

How to Cite

Rifat, M. A., Huda, M. N., Parray, A. A., Yadav, U. N., Mahumud, R. A., Ali, A. M., & Mistry, S. K. (2022). Global COVID-19 vaccine equity and the booster dose in low-resource countries: A decolonizing global health perspective. Global Biosecurity, 4(1). https://doi.org/10.31646/gbio.160

Issue

Section

Editorials and Commentaries
Received 2022-04-29
Accepted 2022-05-26
Published 2022-08-02